PRO Program

Saturday, October 22 - Sunday, October 23

Returning for its fifth year, the Practical Radiation Oncology (PRO) Program continues to support the field with a two-day program specifically designed for the community practice radiation oncologist. This program takes place Saturday and Sunday to allow for doctors unable to leave their practice for a week to attend the premier scientific radiation oncology event. Program content is curated to address the needs of a community practice physician and will include disease site reviews, interactive case-based discussions, a coding update and a scientific overview. New this year, in addition to being available at a discounted rate as a weekend-only event, the PRO Program will also be included in the full registration package allowing all attendees access.

Day 1 Schedule of Events: October 22
Time Event
7:45 a.m. - 8:00 a.m. PRO Program Welcome
Speaker: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital
8:00 a.m. - 9:15 a.m. Session I – HPV Head and Neck Cancer: Maintaining Control While Minimizing Toxicity
Moderator: Arshin Sheybani, MD, John Stoddard Cancer Center

Speakers:
Management of p16+ Unknown Primary of the Head and Neck
Zain Husain, MD, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto

Adjuvant Therapy After TORS for BOT Carcinoma
Darrion Mitchell, MD, PhD, The Ohio State University Wexner Medical Center

Management Options for Poor Performance Status Patient
Virginia Diavolitsis, MD, The Ohio State University Wexner Medical Center

Q&A
9:30 a.m. - 10:45 a.m. Session II – Management of Brain and Spine Metastases
Moderators: Christine Chung, MD, Alta Bates Comprehensive Cancer Center
Virginia Diavolitsis, MD, The Ohio State University Wexner Medical Center

Speakers:
Management of Brain Metastases With Targeted Therapy
Lindsey Sloan, MD, PhD, University of Minnesota

Management of Large Volume or Multiple Brain Metastases
Tony Wang, MD, Columbia University Irving Medical Center

Management of Spine Metastases with SBRT
Kristin Redmond, MD, MPH, Johns Hopkins University School of Medicine

Q&A
11:00 a.m. - 12:15 p.m. Session III – The Role of Radiation in Diffuse Large B-cell Lymphoma
Moderators: Arshin Sheybani, MD, John Stoddard Cancer Center
Christopher Hayes Pope, MD, CARTI Cancer Center

Speakers:
Overview of High Grade and Diffuse Large B-cell Lymphoma
Yolanda Tseng, MD, University of Washington

Management of Early Stage DLBCL
Bouthaina Dabaja, MD, FASTRO, The University of Texas MD Anderson Cancer Center

Role of Radiation Therapy in Relapsed or Refractory DLBCL
Christopher Kelsey, MD, FASTRO, Duke University Medical Center

The Role of Radiation Therapy in Palliation and Beyond
Timothy Robinson, MD, PhD, H. Lee Moffitt Cancer Center and Research Institute

Q&A
12:15 p.m. - 1:00 p.m. Break
1:00 p.m. - 2:15 p.m. Session IV – Socioeconomic Session 1) Career Advancement for the Physician in Healthcare Organizations 2) Socioeconomic Update
Moderator: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital

Speakers:
Career Advancement for the Physician in Healthcare Organizations
Constantine Mantz, MD, FASTRO, GenesisCare

Socioeconomic Update
Anne Hubbard, MBA, American Society for Radiation Oncology

Q&A
2:15 p.m. - 3:30 p.m. Session V – PRO: Gastrointestinal Cancer
Moderators: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital
Christine Chung, MD, Alta Bates Comprehensive Cancer Center
 
Speakers:
Liver SBRT
Aisling Barry, MD, Princess Margaret Cancer Centre, University Health Network, University of Toronto

Choosing Options in Rectal Cancer
Jessica Frakes, MD, H. Lee Moffitt Cancer Center and Research Institute

Update on GI Cancer
Randa Tao, MD, University of Utah
 
Q&A
3:45 p.m. - 5:00 p.m. Session VI – PRO: Gynecologic Cancers: Practical Applications of Recent Data and Techniques
Moderator: Beant Gill, MD, Associates in Radiation Medicine

Speakers:
Endometrial Cancer: Stage IIIC Disease and Molecular Testing
Ann Klopp, MD. PhD, The University of Texas MD Anderson Cancer Center

Vulvar Cancer: Groin Management in the Era of Sentinel Node Biopsy
Sushil Beriwal, MD, MBA, FASTRO, Allegheny Health Network Cancer Institute

Cervical Cancer: Practical Aspects for Advanced Disease
Yasmin Hasan, MD, University of Chicago

Q&A
5:00 p.m. - 6:15 p.m. Session VII – PRO: Lung: Navigating Treatment Decisions in Small Cell and Non-small Cell Lung Cancer
Moderators: Christopher Hayes Pope, MD, CARTI Cancer Center
Virginia Diavolitsis, MD, The Ohio State University Wexner Medical Center

Speakers:
Radiation Therapy in Limited Stage Small Cell Lung Cancer
Tyler Wilhite, Md, UPMC Hillman Cancer Center

Challenging Non-small Cell Lung Cancer Cases: Ultracentral Non-small Cell Lung Cancer, Mediastinal Failures Post-SBRT, and Definitive Thoracic Re-Irradiation
Mattew Ning, MD, PhD, MD Anderson Cancer Center

Indications for Immunotherapy with Radiation and Role of Checkpoint Blockade in Management of Non-small Cell Lung Cancer
Bradford Perez, MD, H. Lee Moffitt Cancer Center and Research Institute

Q&A
Day 2 Schedule of Events October 23
Time Event
7:45 a.m. - 8:00 a.m. PRO Program Welcome
Speaker: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital
8:00 a.m. - 9:15 a.m. Session VIII – PRO: Oligometastatic Disease
Moderators: Beant Gill, MD, Associates in Radiation Medicine
Christopher Hays Pope, MD, CARTI Cancer Center

Speakers:
Patient Advocacy and Radiation Planning Considerations for Oligometastatic Disease
Beant Gill, MD, Associates in Radiation Medicine

Intersection of Immunotherapy and SABR
Kamran Ahmed, MD, H. Lee Moffitt Cancer Center and Research Institute

Oligopersistent and Oligoprogressive Disease
C. Jillian Tsai, MD, PhD, MS, Memorial Sloan-Kettering Cancer Center

Q&A
9:30 a.m. - 10:45 a.m. Session IX – PRO: Personalized Treatment for Non-Melanoma Skin Cancer
Moderator: Arshin Sheybani, MD, John Stoddard Cancer Center

Speakers:
Personalized Lesion-Based Treatment of Early Stage Skin Cancer
Christopher Barker, MD, Memorial Sloan Kettering Cancer Center

Post-op Radiation for High-risk Cutaneous SCC
John Lukens, MD, University of Pennsylvania

Wide-field Radiation for the Treatment of Field Cancerization
Andrew Potter, MD, Genesis Care

Q&A
11:00 a.m. - 12:15 p.m. Session X – PRO: Considerations for Treatment of PSMA-Staged High-Risk Patients
Moderator: Thomas Boike, MD, MMM, Genesis Care

Speakers:
PSMA PET Staging: Does This Change Everything?
Jeremy De Leon, MBBS, Genesis Care

Treatment of Local Regional Disease in the Era of PSMA PET
Lelie Ballas, MD, University of Southern California

When Occult Mets Become Oligometastatic Disease with PSMA PET Staging
Evan Thomas, MD, PhD, The Ohio State University Wexner Medical Center

Q&A

American Society for Radiation Oncology
251 18th Street South, 8th Floor
Arlington, VA 22202
Telephone: 703-502-1550
www.astro.org

TERMS OF USE & PRIVACY POLICY

Connect With Us: